‘India’s Drug Regulator Approves Astrazeneca/Oxford Vaccine’

50Shares

New Delhi- India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.

The approval paves the way for its rollout in the world’s second worst affected country.

A representative of India’s Central Drugs Standard Control Organization (CDSCO), whose experts are meeting for the second time this week and also considering two other vaccines, declined to comment.

Britain and Argentina have already authorized the vaccine for urgent public use.

India wants to start administering the shots soon.

It is also considering emergency-use authorization applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.

At more than 10 million, India has reported the second highest number of coronavirus cases after the United States, though its rate of infection has come down significantly from a mid-September peak.

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.

ACT NOW
MONTHLYRs 100
YEARLYRs 1000
LIFETIMERs 10000

CLICK FOR DETAILS


Agencies

Leave a Reply

Your email address will not be published.

KO SUPPLEMENTS

Play Indias most popular jackpot and slot games at 7Jackpots get a unique casino bonus on your first deposit.